We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Acorda Therapeutics Inc | NASDAQ:ACOR | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.661 | 0.565 | 0.5878 | 0 | 01:00:00 |
Delaware
|
|
000-50513
|
|
13-3831168
|
(State or other jurisdiction
|
|
(Commission
|
|
(I.R.S. Employer
|
of incorporation)
|
|
File Number)
|
|
Identification No.)
|
|
|
|
|
|
420 Saw Mill River Road, Ardsley, NY
|
|
10502
|
||
(Address of principal executive offices)
|
|
(Zip Code)
|
||
|
|
|
|
|
Registrant's telephone number, including area code:
(914) 347-4300
|
Exhibit No.
|
Description
|
99.1
|
Press Release dated July 28, 2016
|
|
Acorda Therapeutics, Inc.
|
|
|
|
|
July 28, 2016
|
By:
|
/s/ Michael Rogers
|
|
|
Name: Michael Rogers
|
|
|
Title: Chief Financial Officer
|
Exhibit No.
|
Description
|
99.1
|
Press Release dated July 28, 2016
|
1 Year Acorda Therapeutics Chart |
1 Month Acorda Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions